Rajani (drospirenone / ethinyl estradiol / levomefolate calcium) Drug Interactions
A total of 475 drugs are known to interact with Rajani (drospirenone / ethinyl estradiol / levomefolate calcium).
- 55 major drug interactions
- 376 moderate drug interactions
- 42 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Rajani (drospirenone / ethinyl estradiol / levomefolate calcium) and the medicines listed below.
- acetaminophen / hydrocodone
- Benadryl (diphenhydramine)
- cetirizine
- diclofenac
- fluoxetine
- fluticasone nasal
- hydroxyzine
- losartan
- multivitamin with minerals
- Pataday (olopatadine ophthalmic)
- phentermine
- Prozac (fluoxetine)
- risperidone
- sertraline
- tizanidine
- triamterene
- valacyclovir
- Vicks NyQuil Cold & Flu Nighttime Relief (acetaminophen / dextromethorphan / doxylamine)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Rajani (drospirenone / ethinyl estradiol / levomefolate calcium) alcohol/food interactions
There are 4 alcohol/food interactions with Rajani (drospirenone / ethinyl estradiol / levomefolate calcium)
Rajani (drospirenone / ethinyl estradiol / levomefolate calcium) disease interactions
There are 19 disease interactions with Rajani (drospirenone / ethinyl estradiol / levomefolate calcium) which include:
- hyperkalemia
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- bipolar disorder
More about Rajani (drospirenone / ethinyl estradiol / levomefolate calcium)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
